Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57,159,091
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
34,530,294
-
Shares change
-
+119,913
-
Total reported value, excl. options
-
$116,365,282
-
Value change
-
+$265,374
-
Put/Call ratio
-
0%
-
Number of buys
-
40
-
Number of sells
-
43
-
Price
-
$3.37
Institutional Holders of Design Therapeutics, Inc. - Common Stock (DSGN) as of Q2 2025
As of 30 Jun 2025 Design Therapeutics, Inc. - Common Stock (DSGN) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,530,294 shares of stock of the company.
Largest 10 holders included SR One Capital Management, LP, Logos Global Management LP, BlackRock, Inc., Frazier Life Sciences Management, L.P., Point72 Asset Management, L.P., TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Almitas Capital LLC, VANGUARD GROUP INC, and Driehaus Capital Management LLC.
This table shows 105 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.